SRSF2 and myelodysplastic syndrome: In MDS, mutations of SRSF2 (odds ratio 5.7, range: 2.2-14.8) and IDH2 mutations were more enriched with DNMT3A R882 mutations (odds ratio 2.4, range: 1.0-5.8) (Figure 2B).